UNDERUSE OF SPIROMETRY BY FAMILY PHYSICIANS FOR THE DIAGNOSIS OF COPD IN ITALY G. Bettoncelli, G. Caramori, R. Tosatto, F. Arpinelli, G. Visonà, A. Gerace,

Slides:



Advertisements
Similar presentations
COPD Or Chronic Bronchitis That Was Dr Bruce Davies.
Advertisements

GOLD MANAGEMENT PLAN FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
Pulmonary Function Testing
Caring for Patients with COPD: Guidelines for Diagnosis and Management M. Elizabeth Knauft, MD MS September 20, 2007.
BY DR.Khaled Helmy Chest Specialist Al Mahmora Chest Hospital Ministry of Health - Egypt COPD SCOPE ON.
Academy Board Prep PCCM
CHRONIC OBSTRUCTIVE PULMONARY DISEASE Major Killer disease in the world Chronic progressive disease of the lung caused by inhalation of toxic substances.
2008 Guidelines 2.4 DIAGNOSIS IN ADULTS (1) -based on the recognition of a characteristic pattern of symptoms and signs and the absence of an alternative.
Applying best practice for the care of patients with Chronic Obstructive Pulmonary Disease (COPD) Roger Beech Rosie Piggott Plus Sue Ashby Carolyn Chew-Graham.
Burden of COPD Société Belge de Pneumologie Belgische Vereniging voor Pneumologie Danny Galdermans.
COPD MANAGEMENT FALLS SHORT AT RCRMC Jean Solomon, M.D.
Practice Support Program in COPD: South Okanagan Project COPD CARE Algorithm South Okanagan, Interior Health Patricia Rattee RRT, CRE Shannon Walker MD,
Consultants: Jillian Lyon and Mary Ehlers The Impact of Atypical Antipsychotic Use on Obstructive Sleep Apnea.
World Spirometry Day, October 14, 2010 Running a mass spirometry event.
Mrs. Watcharasa Pitug ID The Association between Waist Circumference and Renal Insufficiency among Hypertensive Patients 20/10/58 1.
Manila, Philippines. BOLD Manila, Philippines  COPD a growing cause of morbidity & mortality worldwide  5 th leading cause of death (2001)  3rd in.
Lung-2015 Baltimore, USA July , 2015 Suhaj A.
Normal and abnormal Prof. J. Hanacek, MD, PhD
Lung Volume Reduction Surgery and Quality of Life Amy Burker ALHE 4060/ Masini April 22, 2007.
COPD Diagnosis & Management Anil Ramineni Specialist Respiratory Physiotherapist Community Respiratory Team.
Chronic Obstructive Pulmonary Disease Austin Paul K.
COPD Local Burden. Population Prevalence of GOLD Stage I and Stage II & Doctor Diagnosed COPD in Manila, Philippines Source: BOLD Study, 2007;Dantes R.
Respiratory disease programme for Darlington : a catalyst for change. Dr Basil Penney Sr. Claire Adams Darlington CCG Respiratory Leads.
Definition Chronic obstructive pulmonary disease (COPD) is characterized by chronic airflow limitation and a range of pathological changes in the lung.
Survey of Respiratory Diagnostic Laboratories to Inform the National COPD Strategy T McCarthy,* A McGowan, ¥ M O’Connor,* on behalf of the National COPD.
The evolving role of MDCT in the assessment of patients with chronic obstructive pulmonary disease S. Karia, R. Mahadeva, A. Balan, J. Babar Clinical Radiology.
J R Hurst Thorax : Depart. Of Pulmonology R3 백승숙.
Spirometry tests were carried out by a Respiratory Clinical Nurse Specialist (Respiratory CNS) Participants were referred to see their General Practitioner.
Original article Chronic Renal Failure A Neglected Comorbidity of COPD Raffaele Antonelli Incalzi, MD; Andrea Corsonello, MD; Claudio Pedone, MD; Salvatore.
COPD SPUTUM PRODUCERS AND THE INFLUENCE ON ANTIBIOTIC RESISTANCE Sarah Thurston PhD student.
Long term oxygen therapy for patients with COPD – community resources T McCarthy, M O’Connor, on behalf of the National COPD Strategy Group Population.
Wales Primary Care COPD Audit
An effective COPD case finding strategy in Primary Care
Trial of posaconazole therapy for chronic pulmonary aspergillosis
The Minimal Important Difference for St
Copyright © 2015 by the American Osteopathic Association.
A Survey of Knowledge, Attitudes and Practices of Doctors in General Practice in Singapore Towards Chronic Obstructive Pulmonary Disease Dr David Cheong,
East Tennessee State University
Kjell Torén Section of Occupational and environmental medicine
GARD Meeting Beijing Formulate and Adopt Policy WG 3: Diagnosis of CRD and Allergy
L. V. Luna Diaz1,2, I. Iupe2, B. Zavala2, K. Balestrini1, A. M
Classification of chronic obstructive pulmonary disease (COPD) severity according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD):
Table1. Average Activity Counts
The unrecognized epidemic IN INDIA
Sources: (1) Global Strategy for the diagnosis Management and Prevention of COPD, Global initiative for Chronic Obstructive Lung Disease (GOLD)
Copyright © 2015 by the American Osteopathic Association.
Sample Title First Name, Last Name, Degree
Health Status in Chronic Obstructive Pulmonary Disease: Measuring the Minimal Clinically Important Difference over Different Periods of Time H.J. Alma,
Sample Title First Name, Last Name, Degree
Assessing COPD in Primary Care
COPD.
Primary data collection versus use of retrospective claims data: methodology lessons learned from a linked database study in chronic obstructive pulmonary.
Diagnosis General Guidelines:
Personalized Disease Models on a Chip
Prevalence of true-positive, false-negative and false-positive cases of chronic obstructive pulmonary disease identified with the fixed-limit Global Initiative.
Chronic Obstructive Pulmonary Disease: An Evidence-Based Approach to Treatment With a Focus on Anticholinergic Bronchodilation  Nicholas J. Gross, MD,
Distribution of lower extremity artery disease (LEAD) Fontaine stages over the combined chronic obstructive pulmonary disease (COPD) Global Initiative.
Level of physical activity by Global Initiative for Obstructive Lung Disease (GOLD) stage, BODE (body mass index, FEV1 for airflow obstruction, dyspnoea,
Occurrence of morning symptoms
Personalized Disease Models on a Chip
Diagnosi della BPCO 1.
Launch of new COPD guidelines
3-year survival of lung cancer patients in the general population and in those with a prior diagnosis of chronic obstructive pulmonary disease (COPD).
Screening test accuracy of the final risk score at a threshold of ≥2
Correlation between inspiratory capacity (IC)/total lung capacity (TLC) ratio and oxygen pulse at peak exercise in chronic obstructive pulmonary disease.
Clinical findings in patients with chronic obstructive pulmonary disease according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD)
Prevalence of chronic obstructive pulmonary disease (COPD) defined by different criteria by region. The dark grey bar represents ‘symptom-based COPD’,
Chronic obstructive pulmonary disease (COPD) prevalence (postbronchodilator FEV1/FVC (forced expiratory volume in 1 s/forced vital capacity)
The Global Initiative for Chronic Obstructive Lung Disease (GOLD) ABCD scheme for classifying patients with COPD with separate appraisal of air-flow limitation.
Time taken to perform the Glittre activities of daily living (Glittre ADL) test by severity of COPD obstruction according to Global Initiative for Chronic.
Presentation transcript:

UNDERUSE OF SPIROMETRY BY FAMILY PHYSICIANS FOR THE DIAGNOSIS OF COPD IN ITALY G. Bettoncelli, G. Caramori, R. Tosatto, F. Arpinelli, G. Visonà, A. Gerace, I.M. Adcock, A. Ciaccia

BACKGROUND The Global Initiative for Chronic Obstructive Lung Disease (GOLD) underlines that spirometry is the gold standard as the most reproducible, standardized and objective way of measuring airflow limitation in the diagnosis and assessment of chronic obstructive pulmonary disease (COPD) However, studies undertaken in different countries suggest a widespread underuse of spirometry by family physicians to establish the diagnosis of COPD (Table 1) Precise estimates of the prevalence of physician-diagnosed COPD in Italy are not available in the literature.

AIM OF THE STUDY To investigate the degree of use of spirometry by family physicians to establish the diagnosis of COPD in Italy

METHODS In collaboration with the Italian Academy of Family Physicians (SIMG) a standardized questionnaire has been self-administered to a sample of 2425 Italian family physicians (representing 5% of all the Italian doctors involved in family practice). They have been chosen to cover all the Italian counties.

RESULTS (I) The prevalence of physician-diagnosed COPD in Italy is approximately 4% (Figure 1) 30% of family physicians in Italy do not use spirometry to establish the diagnosis of COPD (Figure 2)

RESULTS (II) The main reasons given by the family physicians for the failure to use spirometry are (Figure 3): - spirometry is not necessary for the diagnosis of COPD - there are logistical limitations to the patients’ access to lung function laboratories

CONCLUSIONS Contrary to GOLD guidelines, in Italy, as with other countries, spirometry is not always used in the diagnosis of COPD by family physicians. There is a clear necessity for further education initiatives targeted to this group of doctors.

Mean national data (±s.d.): 40.5 ±30.9 patients Mean national data (±s.d.): 50.2 ±35.3 patients pazienti Mean number of COPD patients for family physician with 500–1000 people Mean number of COPD patients for family physician with people Figure 1

Spirometry use of family physicians in Italy for COPD diagnosis % Figuermedici n.d ,2% 72,8% 28,0% 72,0% 34,1% 65,9% 0% 50% 100% NorthCentreSouth Yes= 70,0% No = 30,0% Figure 2

0,6% 40,9% 63,3% 0%20%40%60%80% It is not useful Clinical assessment is enough Logistical problems % Figuermedici % medici Figure 3 Main reasons for unuse of spirometry by family physicians in Italy